Recently Featured

Tobacco Settlement Insights: Strategic Allocation of Meta Funds Essential for Public Health

October 2, 2026
The ongoing debate surrounding the allocation of funds from the recent Meta settlement echoes the discussions that took place during the landmark tobacco settlement over two decades ago. As states prepare to receive substantial financial resources, it is crucial to reflect on the lessons learned from the tobacco settlement regarding the prioritization of public health…

Kennedy to Deliver Keynote for Anti-Vaccine Group He Once Led

October 2, 2026
WASHINGTON — Health Secretary Robert F. Kennedy Jr. will give a keynote address at a Children’s Health Defense conference in the nation’s capital this week, embracing the anti-vaccine organization he once led. This event marks a significant moment for the Children’s Health Defense (CHD), as it highlights the ongoing influence of Kennedy within the anti-vaccine…

Summit, Akeso look to shed PD-1/VEGF drug doubts with latest study results

October 2, 2026
As dueling data emerge between their drug ivonescimab and a rival Merck medication, Summit and Akeso revealed new findings that impressed Wall Street. The latest study results suggest that ivonescimab may offer a competitive edge in the PD-1/VEGF inhibitor landscape, particularly in terms of efficacy and safety profiles, which have been critical points of contention…

Abbott agrees to $385 million settlement over Sturgis baby formula plant closure

October 2, 2026
Abbott Laboratories has agreed to a $385 million settlement to resolve claims related to contamination issues at its Sturgis, Michigan baby formula plant, the largest in the U.S. This facility’s problems were significant contributors to the nationwide supply shortages of infant formula in 2022, which raised alarm among parents and healthcare professionals alike. The investigation…

Ongoing Cases